Inhibition of ovulation by a novel progestogen (drospirenone) alone or in combination with ethinylestradiol-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of ovulation by a novel progestogen (drospirenone) alone or in combination with ethinylestradiol

Published:2000-01 Issue:1 Volume:5 Page:16-24
ISSN:1362-5187
Container-title:The European Journal of Contraception & Reproductive Health Care
language:en
Short-container-title:The European Journal of Contraception & Reproductive Health Care

Author:

Rosenbaum P.,Schmidt W.,Helmerhorst F. M.,Wuttke W.,Rossmanith W.,Freundl F.,Thomas K.,Grillo M.,Wolf A.,Heithecker R.

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Obstetrics and Gynaecology,Reproductive Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/13625180008500376

Reference11 articles.

1. Aldosterone antagonists. 4. Synthesis and activities of steroidal 6,6-ethylene-15,16-methylene 17-spirolactones

2. Drospirenone: A novel progestogen with antimineralocorticoid and antiandrogenic activity

3. Dihydrospirorenone, a New Progestogen with Antimineralocorticoid Activity: Effects on Ovulation, Electrolyte Excretion, and the Renin-Aldosterone System in Normal Women

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase I/II study evaluating the pharmacokinetics, pharmacodynamics, and safety of drospirenone as an oral contraceptive in Japanese women;Journal of Obstetrics and Gynaecology Research;2024-01-23

2. Ultrasound-Assisted Extraction, Followed by Gas Chromatography–Mass Spectrometry for the Simultaneous Quantification of Ethinyl Estradiol and Drospirenone in Contraceptive Formulations;Molecules;2023-06-25

3. Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen;Women's Health;2023-01

4. Current Knowledge of Progestin-Only Pills;Electronic Journal of General Medicine;2021-09-08

5. Drospirenone 4 mg-only pill (DOP) in 24+4 regimen: a new option for oral contraception;Expert Review of Clinical Pharmacology;2020-06-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3